SummaryNingbo Cbmtec Medical Equipment Co., Ltd. is identified as a China-based manufacturer/factory operating in Zhejiang and supplying medical and industrial equipment. It reports 10 production lines, 11–20 years of total R&D-engineer experience, and 6–10 quality-control staff. Its product scope includes patient monitors, ventilators, patient lifts, anesthesia machines, ultrasound scanners, gas cylinders, oxygen concentrators, pulse oximeters, and oxygen regulators. The supplier reports BSCI, ISO 9001, and ISO 14001 management-system certifications, and began exporting in 2015, with 51%–70% of sales from exports. Evidence is insufficient to confirm after-sales service, customer cases, customization capability, or financial credibility. The available information supports manufacturing capacity and an established R&D and quality-control structure, but does not independently verify the stated quality guarantee or certification scope.
Supplier typeThe supplier is explicitly identified as a Manufacturer/Factory, with a limited-company structure and a stated factory address in Ningbo, Zhejiang, China. This directly supports classification as a manufacturing supplier rather than only a trading intermediary.
CertificationsThe supplier reports BSCI, ISO 9001, and ISO 14001 certifications under supplier management systems. These certifications are stated in the provided information, although the slices do not provide certificate numbers, validity dates, or scopes.
R&D capabilityThe supplier reports 11–20 years of total R&D-engineer experience and states that it has its own R&D and technical engineers. This supports an established internal technical base, but the slices do not document patents, proprietary technologies, new-product launches, or measurable innovation outcomes.
Production capacityThe supplier reports 10 production lines, 6–10 quality-control staff, and its own manufacturing facilities, while offering a broad range of medical and industrial equipment. These facts support operational manufacturing capability; however, the stated annual output is limited to the category reported and no capacity-utilization or delivery-performance evidence is provided.